132 related articles for article (PubMed ID: 15872381)
21. Cyclooxygenase-2 (COX-2) expression in canine intracranial meningiomas.
Rossmeisl JH; Robertson JL; Zimmerman KL; Higgins MA; Geiger DA
Vet Comp Oncol; 2009 Sep; 7(3):173-80. PubMed ID: 19691646
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines.
Brunelle M; Sartin EA; Wolfe LG; Sirois J; Doré M
Vet Pathol; 2006 Sep; 43(5):656-66. PubMed ID: 16966442
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 expression in human soft-tissue sarcomas is related to epithelial differentation.
Lassus P; Ristimäki A; Huuhtanen R; Tukiainen E; Asko-Seljavaara S; Andersson LC; Miettinen M; Blomqvist C; Haglund C; Böhling T
Anticancer Res; 2005; 25(4):2669-74. PubMed ID: 16080510
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.
Ramos-Vara JA; Miller MA; Valli VE
Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900
[TBL] [Abstract][Full Text] [Related]
25. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.
Passantino L; Passantino G; Cianciotta A; Ribaud MR; Lo Presti G; Ranieri G; Perillo A
Immunopharmacol Immunotoxicol; 2008; 30(3):609-21. PubMed ID: 18608529
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical demonstration of angiogenesis-associated homeobox proteins in canine vascular tumours.
Kodama A; Sakai H; Murakami M; Murai A; Mori T; Maruo K; Yanai T; Masegi T
J Comp Pathol; 2009; 141(2-3):199-203. PubMed ID: 19505696
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
Adachi M; Hoshino Y; Izumi Y; Takagi S
J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
[TBL] [Abstract][Full Text] [Related]
28. Expression of cyclooxygenase-2, P-glycoprotein and multi-drug resistance-associated protein in canine transitional cell carcinoma.
Lee JY; Tanabe S; Shimohira H; Kobayashi Y; Oomachi T; Azuma S; Ogihara K; Inokuma H
Res Vet Sci; 2007 Oct; 83(2):210-6. PubMed ID: 17316722
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of cyclooxygenase-2 in canine ovarian carcinomas.
Borzacchiello G; Russo V; Russo M
J Vet Med A Physiol Pathol Clin Med; 2007 Jun; 54(5):247-9. PubMed ID: 17523957
[TBL] [Abstract][Full Text] [Related]
30. Widespread mismatch repair protein expression in canine cutaneous mast cell tumors.
Munday JS; French AF; Gibson IR; Gwynne K
Vet Pathol; 2009 Mar; 46(2):227-32. PubMed ID: 19261633
[TBL] [Abstract][Full Text] [Related]
31. Resistance of prostate cancer cell lines to COX-2 inhibitor treatment.
Wagner M; Loos J; Weksler N; Gantner M; Corless CL; Barry JM; Beer TM; Garzotto M
Biochem Biophys Res Commun; 2005 Jul; 332(3):800-7. PubMed ID: 15907789
[TBL] [Abstract][Full Text] [Related]
32. Expression of cyclooxygenase-2 in canine renal cell carcinoma.
Khan KN; Stanfield KM; Trajkovic D; Knapp DW
Vet Pathol; 2001 Jan; 38(1):116-9. PubMed ID: 11199159
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression in canine appendicular osteosarcomas.
Mullins MN; Lana SE; Dernell WS; Ogilvie GK; Withrow SJ; Ehrhart EJ
J Vet Intern Med; 2004; 18(6):859-65. PubMed ID: 15638270
[TBL] [Abstract][Full Text] [Related]
34. Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours.
Murakami M; Sakai H; Kodama A; Mori T; Maruo K; Yanai T; Masegi T
J Comp Pathol; 2008 Jul; 139(1):1-7. PubMed ID: 18479697
[TBL] [Abstract][Full Text] [Related]
35. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
Fröberg GK; Lindberg R; Ritter M; Nordlind K
J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
[TBL] [Abstract][Full Text] [Related]
36. Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995-1997).
McManus PM
J Am Vet Med Assoc; 1999 Aug; 215(3):355-7. PubMed ID: 10434973
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.
Wu R; Abramson AL; Shikowitz MJ; Dannenberg AJ; Steinberg BM
Clin Cancer Res; 2005 Sep; 11(17):6155-61. PubMed ID: 16144915
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of interleukin-1alpha and cyclooxygenase-2 in human gastric cancer: a possible role in tumor progression.
Uefuji K; Ichikura T; Mochizuki H
Anticancer Res; 2005; 25(5):3225-30. PubMed ID: 16101131
[TBL] [Abstract][Full Text] [Related]
40. Characterization of mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with lymphocytic-plasmacytic or eosinophilic gastroenterocolitis.
Kleinschmidt S; Meneses F; Nolte I; Hewicker-Trautwein M
Vet Immunol Immunopathol; 2007 Dec; 120(3-4):80-92. PubMed ID: 17850882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
